SCF ENCYCLOPEDIA ENTRY

UTERINE ATONY

SCF-RDOS Registry Code: SCF-RDOS-PPD-HM-003

Disease Type Classification: Obstetric Hemorrhagic Disorder → Uterine Contractility Failure Syndrome → Primary Cause of Postpartum Hemorrhage

Adaptive Module Activation:

• Universal Core Module
• Obstetric Emergency Expansion
• Hematologic Disease Expansion
• Vascular Disease Expansion
• Myometrial Dysfunction Expansion
• Endothelial Dysfunction Expansion
• Multiorgan Perfusion Expansion

1. SCOPE & POSITIONING

Etiology / Classification

Uterine Atony is the failure of the uterus to contract effectively following delivery, resulting in persistent uterine bleeding from the placental implantation site and failure of physiologic postpartum hemostasis.

Following placental separation, normal myometrial contraction compresses maternal spiral arteries and venous sinuses, creating a physiologic “living ligature” mechanism that prevents hemorrhage.

In uterine atony:

• Myometrial contraction is inadequate
• Uterine tone is lost
• Placental-bed vessels remain patent
• Massive hemorrhage may occur rapidly

Uterine atony accounts for approximately 70–80% of Primary Postpartum Hemorrhage cases worldwide and remains the most common cause of severe maternal hemorrhage.

Within the SCF framework, Uterine Atony is classified as:

An acute postpartum myovascular contractility failure syndrome characterized by collapse of coordinated myometrial contraction, failure of uterine vascular compression, and catastrophic hemostatic instability.

SCF Classification

SCF Disease Category: Acute Myometrial Hemostatic Failure Syndrome

SCF Functional Class:

Maternal Uterovascular Contractility Collapse Disorder

SCF Fault Tier Classification

Clinical Significance

Uterine Atony is one of the most dangerous postpartum emergencies and can lead to rapid maternal deterioration.

Potential complications include:

• Massive postpartum hemorrhage
• Hemorrhagic shock
• Disseminated intravascular coagulation (DIC)
• Acute kidney injury
• Hepatic ischemia
• Myocardial ischemia
• Sheehan syndrome
• Multiorgan failure
• Maternal death

SCF Domain Alignment

Primary Domains:

• Obstetric
• Hematologic
• Myometrial
• Vascular

Secondary Domains:

• Endocrine
• Renal
• Hepatic
• Cardiovascular

2. ETIOPATHOGENIC CORE

Primary Cause

Uterine Atony develops when the postpartum uterus fails to generate sufficient coordinated contraction to compress placental-bed blood vessels.

This failure results from disruption of:

• Myometrial calcium signaling
• Oxytocin responsiveness
• Contractile synchronization
• Uterine muscle energetics
• Neurohormonal activation

Key Drivers

Driver A — Myometrial Exhaustion

Excessive uterine workload may occur from:

• Prolonged labor
• Obstructed labor
• Oxytocin overexposure

Result:

• Contractile fatigue

Driver B — Uterine Overdistension

Common causes:

• Multiple gestation
• Polyhydramnios
• Macrosomia

Result:

• Impaired postpartum contractility

Driver C — Oxytocin Receptor Desensitization

Prolonged oxytocin exposure may produce:

• Receptor downregulation
• Reduced signaling responsiveness

Result:

• Failure of uterine contraction

Driver D — Myometrial Structural Dysfunction

Associated conditions:

• Fibroids
• Chorioamnionitis
• Uterine anomalies

Result:

• Mechanical contractile impairment

Driver E — Bioenergetic Failure

Myometrial contraction requires:

• ATP availability
• Calcium mobilization
• Mitochondrial function

Result:

• Reduced contractile force generation

3. SCF FAULT ARCHITECTURE

4. PATHOGENESIS FLOW (SCF LOGIC)

Delivery

↓

Placental Separation

↓

Failure of Coordinated Myometrial Contraction

↓

Loss of Uterine Tone

↓

Failure of Spiral Artery Compression

↓

Persistent Placental-Bed Blood Flow

↓

Massive Uterine Bleeding

↓

Acute Blood Volume Loss

↓

Hemodynamic Instability

↓

Systemic Hypoperfusion

↓

Hemorrhagic Shock

↓

Multiorgan Dysfunction

5. CLINICAL SPECTRUM

6. SCF TRINITY FRAMEWORK MAPPING

Trinity Axis I — Structural Integrity

Affected Systems:

• Myometrium
• Placental implantation site
• Uterine vasculature

Primary Failure:

• Mechanical vascular compression failure

Trinity Axis II — Energetic Integrity

Affected Systems:

• Myometrial mitochondria
• ATP generation pathways
• Calcium cycling systems

Primary Failure:

• Contractile bioenergetic insufficiency

Trinity Axis III — Informational Integrity

Affected Systems:

• Oxytocin receptor signaling
• Calcium signaling networks
• Neurohormonal regulation

Primary Failure:

• Contractility synchronization collapse

7. MYOMETRIAL FAILURE EXPANSION MODULE

Clinical Subtype Registry

Type A

Classic Uterine Atony

Characteristics:

• Most common presentation
• Generalized contractility failure

Type B

Overdistension-Associated Atony

Characteristics:

• Multiple gestation
• Polyhydramnios
• Macrosomia

Type C

Oxytocin-Refractory Atony

Characteristics:

• Receptor desensitization
• Reduced pharmacologic responsiveness

Type D

Inflammatory Atony

Characteristics:

• Chorioamnionitis association
• Myometrial inflammatory dysfunction

Type E

Refractory Atonic Hemorrhage

Characteristics:

• Resistant to standard therapy
• Escalation to procedural management

8. MULTI-OMICS PATHOGENESIS MAP

9. SCF PCR THERAPEUTIC STRATEGY

PREVENTATIVE

Objectives

Prevent postpartum contractility failure.

Targets:

• Uterine tone preservation
• Hemostatic readiness
• Oxytocin responsiveness
• High-risk identification

CURATIVE

Objectives

Restore uterine contraction and achieve hemorrhage control.

Targets:

• Myometrial contractility
• Vascular compression
• Active hemorrhage
• Hemodynamic instability

Interventions:

• Uterine massage
• Uterotonic therapies
• Hemostatic resuscitation
• Mechanical tamponade
• Surgical intervention when required

RESTORATIVE

Objectives

Restore uterine integrity and systemic physiologic stability.

Targets:

• Myometrial recovery
• Endothelial repair
• Organ reperfusion
• Hematologic restoration

Potential strategies:

• Precision myometrial activation platforms
• SCF-derived uterovascular stabilizers
• Endothelial recovery therapeutics
• Organ-protective reperfusion strategies

10. CURRENT STANDARD OF CARE

Diagnostic Evaluation

Immediate Clinical Assessment

• Uterine tone examination
• Quantified blood loss
• Hemodynamic monitoring
• Placental inspection

Laboratory Assessment

• Complete blood count
• Fibrinogen
• PT/INR
• aPTT
• Lactate
• Blood type and crossmatch

Advanced Evaluation

When indicated:

• Ultrasound for retained products
• Coagulation investigation
• Massive hemorrhage assessment

Treatment

First-Line Management

• Uterine massage
• Oxytocin administration
• Intravenous access and fluid resuscitation

Escalation Therapy

• Additional uterotonic agents
• Intrauterine balloon tamponade
• Compression sutures

Advanced Hemorrhage Control

• Uterine artery embolization
• Arterial ligation
• Peripartum hysterectomy

11. SCF THERAPEUTIC ENGINEERING OPPORTUNITIES

SCF Target Cluster A

Myometrial Activation Platform

Targets:

• Oxytocin receptor signaling
• Calcium flux regulation
• Contractile synchronization

SCF Target Cluster B

Uterovascular Compression Platform

Targets:

• Spiral artery closure
• Placental-bed hemostasis
• Mechanical compression pathways

SCF Target Cluster C

Hemostatic Stabilization Platform

Targets:

• Clot formation
• Platelet activation
• Fibrin reinforcement

SCF Target Cluster D

Organ Perfusion Protection Platform

Targets:

• Ischemia prevention
• Mitochondrial preservation
• Endothelial stabilization

12. TRANSLATIONAL BLUEPRINT

Diagnostic Biomarkers

Hemostatic

• Fibrinogen
• D-dimer
• Platelet count

Perfusion

• Lactate
• Base deficit

Contractility

• Oxytocin receptor expression biomarkers (research)
• Myometrial contractility markers (research)

Organ Injury

• Creatinine
• ALT/AST
• Cardiac biomarkers

Clinical Endpoints

Primary:

• Hemorrhage cessation

Secondary:

• Restoration of uterine tone
• Hemodynamic stabilization
• Organ preservation
• Maternal survival

FDA Translational Pathway

Preclinical

↓

IND

↓

Phase I Safety

↓

Phase II Hemostatic Efficacy

↓

Phase III Maternal Outcomes

↓

NDA/BLA Submission

13. SCF DBI INTERPRETATION

Decentralized Biological Intelligence Failure

Cellular Layer

Myometrial cells fail to coordinate calcium-mediated contraction.

Tissue Layer

The uterine muscle loses synchronized force generation capacity.

Organ Layer

The uterus fails to perform its critical postpartum hemostatic function.

System Layer

Hemostatic, vascular, endocrine, and perfusion networks become progressively destabilized.

Whole-Organism Layer

Maternal recovery after delivery is interrupted by catastrophic failure of uterine vascular closure mechanisms.

14. SCF LAYMAN’S SUMMARY

Uterine Atony occurs when the uterus fails to contract properly after childbirth. Because uterine contractions normally squeeze shut the blood vessels that supplied the placenta, failure of contraction can cause rapid and severe bleeding.

According to the SCF model, the disorder develops when the uterine muscle loses its ability to generate enough coordinated force to compress the placental-bed blood vessels. As a result, blood continues to flow from the placental site, leading to postpartum hemorrhage.

Common warning signs include:

• Heavy vaginal bleeding
• A soft or “boggy” uterus
• Large blood clots
• Rapid heartbeat
• Dizziness
• Falling blood pressure
• Signs of shock

Uterine Atony is a medical emergency requiring immediate intervention to prevent severe maternal injury or death.

SCF-RDOS INDICATION SUMMARY